Kouchakji Elias 4
4 · FIBROGEN INC · Filed Feb 26, 2021
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Kouchakji Elias
SVP, Clinical Dev, Drug Safety
Transactions
- Award
Common Stock
2021-02-24+20,800→ 152,567 total - Award
Stock Option (Right to Buy)
2021-02-24+39,900→ 39,900 totalExercise: $53.01Exp: 2031-02-24→ Common Stock (39,900 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years.
- [F2]Twenty-five percent of the shares subject to the option vests on March 1, 2022, and the remainder vests in equal amounts quarterly thereafter for the following three years.